Big pharma turns to immunotherapy combos to beat cancer – Financial Times
Financial Times |
Big pharma turns to immunotherapy combos to beat cancer
Financial Times Merck last week became the first company to win approval to use its immunotherapy Keytruda in all patients whose tumours have a particular biological trait or “biomarker”, regardless of where the cancer is located. At Asco, it is due to present full … |
